These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34391136)

  • 1. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing.
    Thevis M; Piper T; Thomas A
    J Pharm Biomed Anal; 2021 Oct; 205():114312. PubMed ID: 34391136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2021 Jan; 13(1):8-35. PubMed ID: 33185038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Subst Use Misuse; 2020; 55(8):1361-1369. PubMed ID: 32186429
    [No Abstract]   [Full Text] [Related]  

  • 6. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical strategy for detecting doping agents in hair.
    Thieme D; Grosse J; Sachs H; Mueller RK
    Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens, sports, and detection strategies for anabolic drug use.
    Walpurgis K; Piper T; Thevis M
    Best Pract Res Clin Endocrinol Metab; 2022 Jul; 36(4):101609. PubMed ID: 35120801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoisomers in sports drug testing: Analytical strategies and applications.
    Thomas A; Thevis M
    J Chromatogr A; 2022 Jul; 1674():463154. PubMed ID: 35613502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry.
    Piper T; Schänzer W; Thevis M
    J Steroid Biochem Mol Biol; 2016 Sep; 162():80-91. PubMed ID: 26699683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Pain Killers on the Urinary Anabolic Steroid Profile.
    Stoll A; Iannone M; De Gregorio G; de la Torre X; Molaioni F; Botrè F; Kristina Parr M
    J Anal Toxicol; 2020 Dec; 44(8):871-879. PubMed ID: 32390041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the in vivo metabolism of methylstenbolone and detection of novel long term metabolites for doping control analysis.
    Piper T; Fusshöller G; Schänzer W; Lagojda A; Kuehne D; Thevis M
    Drug Test Anal; 2019 Nov; 11(11-12):1644-1655. PubMed ID: 31733090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
    Thevis M; Schänzer W
    Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling the inclusion of non-hydrolysed sulfated long term anabolic steroid metabolites in a screening for doping substances by means of gas chromatography quadrupole time-of-flight mass spectrometry.
    Albertsdóttir AD; Van Gansbeke W; Van Eenoo P; Polet M
    J Chromatogr A; 2021 Apr; 1642():462039. PubMed ID: 33735641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and doping control.
    Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome.
    Thevis M; Görgens C; Guddat S; Thomas A; Geyer H
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14228. PubMed ID: 36539355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual banned-substance review: the Prohibited List 2008-analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2009 Jan; 1(1):4-13. PubMed ID: 20355153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2015 Jan; 7(1):1-20. PubMed ID: 25545248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.